{ "cik": 1531177, "cik_padded": "0001531177", "entityName": "Sight Sciences, Inc.", "fiscal_years": [ { "accn": "0001193125-26-091558", "filed": "2026-03-04", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 224000.0, "cash": 91965000.0, "cost_of_revenue": 10697000.0, "eps_diluted": -0.74, "free_cash_flow": -29918000.0, "gross_profit": 66666000.0, "net_income": -38426000.0, "operating_cash_flow": -29694000.0, "operating_income": -37099000.0, "revenue": 77363000.0, "stockholders_equity": 63942000.0, "total_assets": 115300000.0, "total_liabilities": 51358000.0 }, "period_end": "2025-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.8617297674598968, "leverage": 0.8031966469613087, "net_margin": -0.49669738764008636, "operating_margin": -0.4795444850897716, "revenue_growth_yoy": -0.031339994490772044, "roa_avg2y": -0.2977155718430768, "roa_period_end": -0.33326973113616654, "roe_avg2y": -0.5073911464694814, "roe_period_end": -0.6009508617184324 } }, { "accn": "0001193125-26-091558", "filed": "2026-03-04", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 385000.0, "cash": 120357000.0, "cost_of_revenue": 11581000.0, "eps_diluted": -1.03, "free_cash_flow": -22736000.0, "gross_profit": 68285000.0, "net_income": -51507000.0, "operating_cash_flow": -22351000.0, "operating_income": -50532000.0, "revenue": 79866000.0, "stockholders_equity": 87523000.0, "total_assets": 142839000.0, "total_liabilities": 55316000.0 }, "period_end": "2024-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.8549946159817695, "leverage": 0.6320167270317516, "net_margin": -0.6449177372098265, "operating_margin": -0.6327097888964015, "revenue_growth_yoy": -0.014681208053691275, "roa_avg2y": -0.3328508190894698, "roa_period_end": -0.36059479553903345, "roe_avg2y": -0.4958842388007972, "roe_period_end": -0.5884967380002971 } }, { "accn": "0001193125-26-091558", "filed": "2026-03-04", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 791000.0, "cash": 138129000.0, "cost_of_revenue": 11881000.0, "eps_diluted": -1.14, "free_cash_flow": -47975000.0, "gross_profit": 69175000.0, "net_income": -55547000.0, "operating_cash_flow": -47184000.0, "operating_income": -57274000.0, "revenue": 81056000.0, "stockholders_equity": 120215000.0, "total_assets": 166651000.0, "total_liabilities": 46436000.0 }, "period_end": "2023-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.8534223253059613, "leverage": 0.38627459135715175, "net_margin": -0.6852916502171338, "operating_margin": -0.7065979076194236, "revenue_growth_yoy": 0.13633623529741626, "roa_avg2y": -0.2925651262495918, "roa_period_end": -0.3333133314531566, "roe_avg2y": -0.3963523623662551, "roe_period_end": -0.4620638023541155 } }, { "accn": "0000950170-25-035500", "filed": "2025-03-07", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 970000.0, "cash": 185000000.0, "cost_of_revenue": 12361000.0, "eps_diluted": -1.8, "free_cash_flow": -76935000.0, "gross_profit": 58970000.0, "net_income": -86242000.0, "operating_cash_flow": -75965000.0, "operating_income": -83954000.0, "revenue": 71331000.0, "stockholders_equity": 160076000.0, "total_assets": 213073000.0, "total_liabilities": 52997000.0 }, "period_end": "2022-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.8267092848831504, "leverage": 0.33107398985481895, "net_margin": -1.2090395480225988, "operating_margin": -1.1769637324585385, "revenue_growth_yoy": 0.4570430590734537, "roa_avg2y": -0.3496824183643887, "roa_period_end": -0.40475330051203107, "roe_avg2y": -0.43980488700428116, "roe_period_end": -0.5387565906194558 } }, { "accn": "0000950170-24-030278", "filed": "2024-03-13", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 813000.0, "cash": 260687000.0, "cost_of_revenue": 8610000.0, "eps_diluted": -2.36, "free_cash_flow": -53353000.0, "gross_profit": 40346000.0, "net_income": -62960000.0, "operating_cash_flow": -52540000.0, "operating_income": -51478000.0, "revenue": 48956000.0, "stockholders_equity": 232107000.0, "total_assets": 280186000.0, "total_liabilities": 48079000.0 }, "period_end": "2021-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.8241277882179917, "leverage": 0.207141533861538, "net_margin": -1.28605278209004, "operating_margin": -1.051515646703162, "revenue_growth_yoy": 0.7712011577424023, "roa_avg2y": -0.35672196537032, "roa_period_end": -0.22470787262746889, "roe_avg2y": -0.8789736000781806, "roe_period_end": -0.2712542060342859 } }, { "accn": "0000950170-23-008526", "filed": "2023-03-16", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 953000.0, "cash": 61511000.0, "cost_of_revenue": 9209000.0, "free_cash_flow": -33127000.0, "gross_profit": 18431000.0, "net_income": -34693000.0, "operating_cash_flow": -32174000.0, "operating_income": -32188000.0, "revenue": 27640000.0, "stockholders_equity": -88849000.0, "total_assets": 72806000.0, "total_liabilities": 44324000.0 }, "period_end": "2020-12-31", "ratio_units": { "gross_margin": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "gross_margin": 0.6668234442836469, "net_margin": -1.2551736613603472, "operating_margin": -1.1645441389290883, "roa_period_end": -0.47651292475894846, "roe_avg2y": 0.4834183318005741 } }, { "accn": "0000950170-22-004563", "filed": "2022-03-24", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "stockholders_equity": "USD" }, "fundamentals": { "stockholders_equity": -54683000.0 }, "period_end": "2019-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001193125-26-091558", "filed": "2026-03-04", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "3841", "sic_description": "Surgical & Medical Instruments & Apparatus", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001531177.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001531177.json" }, "ticker": "SGHT" }